Description
DiMNF (14756-24-2) is a selective aryl hydrocarbon receptor (AHR) modulator (SAhRM). It exhibits antiinflammatory activity including suppression of cytokine-mediated acute phase genes through dissociation of non-dioxin-response element (DRE) AHR activity from DRE-dependent xenobiotic gene expression.1DiMNF represses the cytokine-mediated induction of CD55 and therefore may have therapeutic potential in regulating the immune response to tumor formation.2Represses estrogen-inducible transcription.3
Uses
3'',4''-Dimethoxy-α-naphthoflavone (DiMNF) is a potent and selective aryl hydrocarbon receptor (AHR) modulator (SAhRM). Studies show that DiMNF suppresseses cytokine-mediated complement factor gene expression through selective activation of the Ah receptor. DiMNF has therapeutic potential in regulating the immune response to tumor formation.
Uses
3',4'-Dimethoxy-α-naphthoflavone (DiMNF) is a potent and selective aryl hydrocarbon receptor (AHR) modulator (SAhRM). Studies show that DiMNF suppresseses cytokine-mediated complement factor gene expression through selective activation of the Ah receptor. DiMNF has therapeutic potential in regulating the immune response to tumor formation.
References
[1] IAIN A MURRAY. Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3’,4’-dimethoxy-α-naphthoflavone.[J]. Molecular Pharmacology, 2011, 79 3: 508-519. DOI:
10.1124/mol.110.069369[2] GITANJALI A NARAYANAN. Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure.[J]. Journal of Pharmacology and Experimental Therapeutics, 2012, 342 2: 345-355. DOI:
10.1124/jpet.112.193482[3] MARK P LABRECQUE. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.[J]. PLoS ONE, 2012: e29545. DOI:
10.1371/journal.pone.0029545